Risk of squamous cell carcinoma in patients treated for basal cell carcinoma with Vismodegib or other therapies

ENCePP Code of conduct

No

Data sources

• Data sources (types):
  Other
• Data sources (types), other:
  Four Vismodegib clinical trials, and one prospective cohort study on standard therapy

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No